Ondo Finance launched ENLVon, a tokenized representation of Enlivex Ltd. (NASDAQ: ENLV) ordinary shares on its Global Markets platform, the companies announced.

The tokenization allows non-U.S. retail and institutional investors to gain economic exposure to Enlivex shares through digital infrastructure without requiring a traditional brokerage account. ENLVon can be held in compatible digital wallets and transferred subject to platform and regulatory requirements.

The tokenized shares enable fractional exposure with low minimum investment amounts and near-instant settlement. They may be integrated into financial applications, including use as collateral or within lending and yield-generating strategies.

According to the announcement, the tokenized stock market recently surpassed $1 billion in on-chain value. Ondo holds approximately 61% market share with roughly $653 million in tokenized stock value, supporting about 265 tokenized securities and ETFs across Ethereum, BNB Chain, and Solana blockchain networks.

Enlivex CEO Oren Hershkovitz said the tokenization represents an extension of the company's efforts to align with innovation at the intersection of capital markets and blockchain infrastructure. He noted that ENLVon expands accessibility to digitally native investors.

Enlivex describes itself as a quality longevity company powered by a prediction markets treasury. The company is developing Allocetra, a clinical-stage immunotherapy targeting inflammatory conditions associated with aging, with focus on age-related osteoarthritis. Enlivex also operates a prediction markets treasury strategy using the Rain protocol on Arbitrum.